Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

In this episode of Invst Guru, we spotlight Plunge, the Sacramento-based company bringing cold plunge systems and saunas to homes, gyms, and hospitality partners worldwide. We explore the company’s origins, rapid revenue growth, brand partnerships, and technology roadmap. The conversation also covers both bullish and bearish outlooks, highlighting opportunities in the wellness sector alongside risks tied to hardware, competition, and consumer demand.

⚖ Disclaimer: This episode is for informational purposes only and does not constitute investment advice or a solicitation to invest. Invst Guru is not affiliated with Plunge, Wefunder, or any broker-dealer. Any investment in private or early-stage companies involves risk, including the potential loss of your entire investment. All investments in Plunge must be made through its official Regulation Crowdfunding (Reg CF) campaign page on Wefunder.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

HeavyTech isn’t retrofitting diesel gear to meet new standards—they’re rethinking the entire machine. In this episode, we unpack how this U.S.-based OEM is developing a line of modular, hybrid-electric construction equipment from the ground up.

You’ll hear about:

• Why legacy OEMs are struggling to adapt
• HeavyTech’s approach to modular platforms and real-time diagnostics
• The founding team’s deep manufacturing background
• The company’s decision to build in Fort Wayne, Indiana
• What makes their Reg CF raise different from hype-driven campaigns

Disclaimer:

This episode is for informational purposes only and does not constitute investment advice or a solicitation to invest. Invst Guru is not affiliated with HeavyTech, Silicon Prairie Capital Partners, or any broker-dealer. If HeavyTech is conducting a Regulation Crowdfunding (Reg CF) campaign, all investments must be made through a registered intermediary. Always consult official offering documents and a licensed advisor before making investment decisions.

Hosted on Acast. See acast.com/privacy for more information.

Description:

In this episode, we profile Toro Bravo 4x4, a startup developing a heavy-duty, dual-purpose RV designed to haul gear during the week and support off-grid living on weekends. Built on a Ford F-550 chassis, the TB44 is engineered for tradespeople, remote workers, and small business owners who need more than a standard RV. We explore the company’s current Reg CF raise on StartEngine, the problem they’re solving, and the market opportunity behind this utilitarian hardware play.

This episode is for informational purposes only and does not constitute investment advice. Toro Bravo 4x4 is conducting a Regulation Crowdfunding offering on a registered platform. All investment activity must take place through that platform.

Ask ChatGPT

Hosted on Acast. See acast.com/privacy for more information.

When Jonathan Benassaya was diagnosed with melanoma, it changed more than his health—it reshaped his mission. In this episode, we explore how that moment sparked the creation of SkinBit, a health tech startup building an AI-powered skin cancer screening system that aims to make early detection faster, more accessible, and scalable.

Jonathan—best known for founding Deezer and leading teams at Meta and Life360—joins us to share the deeply personal story behind SkinBit, the challenges of building medical-grade AI, and why the company is inviting public investors to join their journey via Regulation Crowdfunding on Wefunder.

We also dive into:

• The clinical problem SkinBit is tackling
• How their AI works and why full-body imaging matters
• Regulatory strategy and product deployment plans
• What makes SkinBit’s “scanner-as-a-service” model unique
• Lessons learned from scaling in regulated markets

Whether you’re an investor, founder, or just passionate about the intersection of healthcare and technology, this is a conversation you won’t want to miss.

Hosted on Acast. See acast.com/privacy for more information.

Ravel Health was born from frustration—two founders navigating years of chronic Lyme disease without answers. Now, they’re building a virtual clinic for patients like them, offering integrative, long-form care to individuals dealing with complex illnesses such as mold toxicity, Epstein-Barr, and Long COVID.

In this episode, we explore:

• Why the chronic illness market is so underserved
• How Ravel’s care model works—and what sets it apart from urgent-care telehealth
• Lessons from their six-month pilot and expansion to 46 states
• How they’re scaling with a Regulation Crowdfunding campaign
• What their early investors and advisors see in the opportunity

Whether you're exploring digital health trends, investing in healthcare innovation, or simply curious about how startup founders are reshaping the patient experience, this episode offers insight into a mission-driven venture built by patients, for patients.

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we delve into the science and story behind Peptinovo Biopharma, a biotech startup developing a lipid-mimicking nanotechnology platform that could revolutionize the delivery of chemotherapy. Instead of inventing new drugs, Peptinovo is redesigning how trusted ones, such as paclitaxel, reach their targets, aiming for fewer side effects and better outcomes.

Now raising via Reg CF, Peptinovo invites retail investors to support the next chapter of clinical development. We break down the science, market opportunity, and risks in plain English.

🧾 Disclaimer: This episode is for informational purposes only. Invst Guru is not affiliated with Peptinovo Biopharma, the offering platform, or any broker-dealer. This is not investment advice or a solicitation to invest. All investment activity under Regulation Crowdfunding must occur via a registered funding portal. To learn more, visit the company’s offering page at https://hi.switchy.io/PeptinovoJULY25.

Hosted on Acast. See acast.com/privacy for more information.

In this episode of The Invst Guru Spotlight, we explore the behavioral science behind Qube Money — a fintech platform built to enforce intentional spending at the moment of purchase. Unlike traditional budgeting apps that analyze past behavior, Qube takes a real-time approach using patented transaction-level authorization.

Join us as we explore how Qube's envelope-style budgeting model operates, why retention metrics indicate significant user engagement, and how the company is positioning itself in a competitive fintech market. We also discuss their active Regulation Crowdfunding campaign on StartEngine, the risks associated with early-stage investments, and what sets Qube apart from other neobanks.

🚨 Regulation Crowdfunding Disclaimer:

This episode mentions a company currently raising capital under Regulation Crowdfunding (Reg CF). No investment terms are provided in this podcast. All investments must be made through the official intermediary platform. Please visit Qube’s campaign page on StartEngine to review offering documents, risks, and disclosures before making any investment decisions.

Hosted on Acast. See acast.com/privacy for more information.